Raymond James Financial Services Advisors, Inc. Bio Rad Laboratories, Inc. Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 24, 2023	SELL	$350.25 - $422.63 $14,010 - $16,905	-40 Reduced 4.5%	848 $303,000
Q2 2023 Jul 25, 2023	SELL	$359.49 - $486.4 $482,076 - $652,262	-1,341 Reduced 60.16%	888 $336,000
Q1 2023 Apr 14, 2023	BUY	$418.69 - $503.0 $578,629 - $695,146	1,382 Added 163.16%	2,229 $1.07 Million
Q4 2022 Feb 08, 2023	SELL	$351.71 - $456.01 $45,018 - $58,369	-128 Reduced 13.13%	847 $356,000
Q3 2022 Oct 25, 2022	BUY	$412.59 - $563.26 $18,979 - $25,909	46 Added 4.95%	975 $407,000
Q2 2022 Aug 12, 2022	BUY	$463.67 - $597.16 $1,391 - $1,791	3 Added 0.32%	929 $460,000
Q1 2022 May 11, 2022	SELL	$524.57 - $735.42 $788,428 - $1.11 Million	-1,503 Reduced 61.88%	926 $522,000
Q4 2021 Feb 08, 2022	BUY	$708.84 - $794.68 $761,294 - $853,486	1,074 Added 79.26%	2,429 $1.84 Million
Q3 2021 Nov 02, 2021	BUY	$657.71 - $825.77 $53,274 - $66,887	81 Added 6.36%	1,355 $1.01 Million
Q2 2021 Aug 11, 2021	BUY	$576.64 - $649.04 $66,313 - $74,639	115 Added 9.92%	1,274 $821,000
Q1 2021 May 14, 2021	SELL	$547.01 - $662.35 $543,180 - $657,713	-993 Reduced 46.14%	1,159 $662,000
Q4 2020 Feb 12, 2021	SELL	$510.68 - $643.45 $189,972 - $239,363	-372 Reduced 14.74%	2,152 $1.25 Million
Q3 2020 Nov 04, 2020	BUY	$454.43 - $535.6 $788,890 - $929,801	1,736 Added 220.3%	2,524 $1.3 Million
Q2 2020 Jul 17, 2020	BUY	$334.87 - $493.06 $24,780 - $36,486	74 Added 10.36%	788 $356,000
Q1 2020 Apr 21, 2020	SELL	$320.01 - $409.07 $273,288 - $349,345	-854 Reduced 54.46%	714 $250,000
Q4 2019 Feb 12, 2020	SELL	$319.73 - $374.2 $53,714 - $62,865	-168 Reduced 9.68%	1,568 $580,000
Q3 2019 Nov 07, 2019	BUY	$304.55 - $345.24 $104,765 - $118,762	344 Added 24.71%	1,736 $578,000
Q2 2019 Aug 06, 2019	BUY	$286.93 - $312.59 $3,156 - $3,438	11 Added 0.8%	1,392 $435,000
Q1 2019 May 06, 2019	SELL	$224.3 - $317.41 $312,225 - $441,834	-1,392 Reduced 50.2%	1,381 $422,000
Q4 2018 Feb 11, 2019	SELL	$220.1 - $309.0 $35,436 - $49,749	-161 Reduced 5.49%	2,773 $644,000
Q3 2018 Nov 14, 2018	BUY	$289.28 - $326.15 $21,695 - $24,461	75 Added 2.62%	2,934 $918,000
Q2 2018 Jul 30, 2018	SELL	$244.1 - $303.88 $2,196 - $2,734	-9 Reduced 0.31%	2,859 $825,000
Q1 2018 Apr 16, 2018	SELL	$233.97 - $274.11 $783,565 - $917,994	-3,349 Reduced 53.87%	2,868 $717,000
Q4 2017 Feb 09, 2018	BUY	$216.94 - $271.3 $40,784 - $51,004	188 Added 3.12%	6,217 $1.48 Million
Q3 2017 Oct 26, 2017	SELL	$212.27 - $242.28 $71,110 - $81,163	-335 Reduced 5.26%	6,029 $1.34 Million
Q2 2017 Aug 15, 2017	BUY	N/A	6,364	6,364 $1.44 Million

Others Institutions Holding BIO

# of Institutions

457

Shares Held

18.2M

Call Options Held

19.5K

Put Options Held

13.9K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.41B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account